Gut dysbiosis, low-grade inflammation, and renal impairment severity in elderly diabetic nephropathy

Table 10 Comparison of changes in glucose and lipid metabolism indicators between the progressive group and the stable group

Variables	Progress group (n = 118)	Stable group (n = 134)	t	P value
FBG (mmol/L)	-0.51 ± 0.22	-0.16 ± 0.24	-11.635	0.000
PBG (mmol/L)	-0.72 ± 0.35	-0.21 ± 0.38	-11.253	0.000
HbA1c (%)	-0.64 ± 0.30	-0.19 ± 0.35	-10.798	0.000
FINS (pmol/mL)	-4.62 ± 3.98	1.55 ± 3.87	-12.523	0.000
HOMA-IR	-2.44 ± 1.61	0.29 ± 1.51	-13.897	0.000
TC (mmol/L)	-0.73 ± 0.60	0.34 ± 0.71	-12.609	0.000
TG (mmol/L)	-0.34 ± 0.27	0.14 ± 0.24	-13.969	0.000
LDL-C (mmol/L)	-0.43 ± 0.32	0.07 ± 0.37	-11.596	0.000
HDL-C (mmol/L)	0.01 ± 0.07	0.06 ± 0.08	-6.113	0.000
FFA (mmol/L)	-0.12 ± 0.12	0.03 ± 0.11	-10.743	0.000

FBG: Fasting blood glucose; PBG: Postprandial blood glucose; HbA1c: Glycated hemoglobin; FINS: Fasting insulin; HOMA-IR: Homeostasis model assessment of insulin resistance; TC: Total cholesterol; TG: Triglycerides; LDL-C: Low-density lipoprotein cholesterol; HDL-C: High-density lipoprotein cholesterol; FFA: Free fatty acids.